Effect of Valsartan on Left Ventricular Myocardial Functions in Hypertensive Patients With Left Ventricular Hypertrophy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01425411

Recruitment Status : Completed

First Posted : August 30, 2011

Last Update Posted : August 30, 2011

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborator:

Novartis Pharmaceuticals

Information provided by (Responsible Party):

Nagehan Kucukler, Mustafa Kemal University

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Completed
Actual Primary Completion Date :	November 2008
Actual Study Completion Date :	November 2008

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Kucukler N, Kurt IH, Topaloglu C, Gurbuz S, Yalcin F. The effect of valsartan on left ventricular myocardial functions in hypertensive patients with left ventricular hypertrophy. J Cardiovasc Med (Hagerstown). 2012 Mar;13(3):181-6. doi: 10.2459/JCM.0b013e3283511f00.

To Top